propafenone has been researched along with A-V Dissociation in 17 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antiarrhythmic efficacy of Propafenone (PF) was evaluated in 24 patients with ventricular hyperkinetic arrhythmias by means of 24-hour Holter monitoring." | 7.67 | [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. ( Cappiello, E; Garimoldi, M; Pirastu, A; Sala, R; Sghirinzetti, M; Terranova, P, 1986) |
| "To evaluate the electrophysiological effects of intravenous propafenone in the anterograde and retrograde effective refractory period of the accessory pathways (AP), in patients with Wolff-Parkinson-White syndrome." | 5.07 | [Acute effects of propafenone in patients with ventricular pre-excitation]. ( Cruz Filho, F; Fagundes, ML; Lorga, AM; Loyola, LH; Maia, IG; Pimenta, J, 1993) |
| "The antiarrhythmic efficacy of Propafenone (PF) was evaluated in 24 patients with ventricular hyperkinetic arrhythmias by means of 24-hour Holter monitoring." | 3.67 | [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. ( Cappiello, E; Garimoldi, M; Pirastu, A; Sala, R; Sghirinzetti, M; Terranova, P, 1986) |
| "Propafenone is an infrequently used class IC antiarrhythmic drug." | 2.39 | Propafenone overdose. ( English, B; Ford, M; Kerns, W, 1994) |
| "Recurrence was not affected by the drug used for cardioversion (P = 0." | 1.40 | Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion. ( Baranchuk, A; Chiale, PA; Conde, D; de Luna, AB; Enriquez, A; Hopman, W; Mondragon, I, 2014) |
| "Propafenone blood level was measured in 75 patients 3-5 hours after propafenone administration." | 1.29 | Effect of steroid eluting versus conventional electrodes on propafenone induced rise in chronic ventricular pacing threshold. ( Cornacchia, D; Fabbri, M; Fazzari, M; Maresta, A; Nigro, P; Peraldo, C; Pistis, G; Puglisi, A; Ricci, R; Sorrentino, F, 1993) |
| " Threshold was tested at baseline and at each dosage after 7 days of therapy." | 1.28 | Effects of oral propafenone therapy on chronic myocardial pacing threshold. ( Altamura, G; Bianconi, L; Boccadamo, R; Carpino, A; Iesi, AP; Serdoz, R; Toscano, S, 1992) |
| "Emergency treatment of cardiac arrhythmias was required in 41 newborn and infants aged two days to 9 months (mean 77 days) from July 1977 until September 1981." | 1.27 | [Emergency treatment of arrhythmias in neonates and infants]. ( Eigster, G; Weber, H; Wesselhoeft, H, 1983) |
| "Propafenone is a type 1c antiarrhythmic drug that recently has become available for clinical trials within the United States." | 1.27 | Propafenone ingestion. ( McHugh, TP; Perina, DG, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enriquez, A | 1 |
| Conde, D | 1 |
| Hopman, W | 1 |
| Mondragon, I | 1 |
| Chiale, PA | 1 |
| de Luna, AB | 1 |
| Baranchuk, A | 1 |
| Vergara, G | 1 |
| Disertori, M | 1 |
| Inama, G | 1 |
| Guarnerio, M | 1 |
| Bettini, R | 1 |
| Durante, G | 1 |
| Stirpe, E | 1 |
| Furlanello, F | 1 |
| Weber, H | 1 |
| Wesselhoeft, H | 1 |
| Eigster, G | 1 |
| Alboni, P | 2 |
| Filippi, L | 1 |
| Pirani, R | 2 |
| Preziosi, S | 1 |
| Paparella, N | 2 |
| Cornacchia, D | 1 |
| Fabbri, M | 1 |
| Maresta, A | 1 |
| Nigro, P | 1 |
| Sorrentino, F | 1 |
| Puglisi, A | 1 |
| Ricci, R | 1 |
| Peraldo, C | 1 |
| Fazzari, M | 1 |
| Pistis, G | 1 |
| Kerns, W | 1 |
| English, B | 1 |
| Ford, M | 1 |
| Maia, IG | 1 |
| Cruz Filho, F | 1 |
| Fagundes, ML | 1 |
| Loyola, LH | 1 |
| Pimenta, J | 1 |
| Lorga, AM | 1 |
| Bianconi, L | 1 |
| Boccadamo, R | 1 |
| Toscano, S | 1 |
| Serdoz, R | 1 |
| Carpino, A | 1 |
| Iesi, AP | 1 |
| Altamura, G | 1 |
| Wunderlich, E | 1 |
| Hief, C | 1 |
| Frohner, K | 1 |
| Podczeck, A | 1 |
| Kaltenbrunner, W | 1 |
| Nürnberg, M | 1 |
| Steinbach, K | 1 |
| Garimoldi, M | 1 |
| Sghirinzetti, M | 1 |
| Pirastu, A | 1 |
| Cappiello, E | 1 |
| Sala, R | 1 |
| Terranova, P | 1 |
| Friocourt, P | 1 |
| Martin, C | 1 |
| Lozac'h, L | 1 |
| Wagner, F | 1 |
| Jähnchen, E | 1 |
| Trenk, D | 1 |
| Eichelbaum, M | 1 |
| Harnasch, P | 1 |
| Hauf, G | 1 |
| Roskamm, H | 1 |
| Katoh, T | 1 |
| Karagueuzian, HS | 1 |
| Sugi, K | 1 |
| Ohta, M | 1 |
| Mandel, WJ | 1 |
| Peter, T | 1 |
| de Lorenzo-Cáceres Ascanio, A | 1 |
| Hernández-Mora, PG | 1 |
| Brezmes Valdivieso, JA | 1 |
| Serrallé Arias de Castro, JR | 1 |
| McHugh, TP | 1 |
| Perina, DG | 1 |
| Candini, GC | 1 |
| Tomasi, AM | 1 |
| Masoni, A | 1 |
1 review available for propafenone and A-V Dissociation
| Article | Year |
|---|---|
Propafenone overdose.
Topics: Adult; Bradycardia; Drug Overdose; Electrocardiography; Heart Block; Humans; Male; Propafenone; Seiz | 1994 |
1 trial available for propafenone and A-V Dissociation
| Article | Year |
|---|---|
[Acute effects of propafenone in patients with ventricular pre-excitation].
Topics: Adolescent; Adult; Atrioventricular Node; Electrocardiography; Female; Heart Block; Humans; Male; Mi | 1993 |
15 other studies available for propafenone and A-V Dissociation
| Article | Year |
|---|---|
Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion.
Topics: Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Electrocardiogra | 2014 |
[Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
Topics: Adult; Aged; Ajmaline; Amiodarone; Electric Stimulation; Electrocardiography; Electrophysiology; Fem | 1984 |
[Emergency treatment of arrhythmias in neonates and infants].
Topics: Arrhythmias, Cardiac; Bradycardia; Critical Care; Female; Heart Arrest; Heart Block; Heart Defects, | 1983 |
[Electrophysiologic effects of propafenone in patients with sinus node dysfunction].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Bradycardia; Female; Heart Block; Heart | 1984 |
Effect of steroid eluting versus conventional electrodes on propafenone induced rise in chronic ventricular pacing threshold.
Topics: Aged; Cardiac Pacing, Artificial; Combined Modality Therapy; Electrocardiography; Electrodes, Implan | 1993 |
Effects of oral propafenone therapy on chronic myocardial pacing threshold.
Topics: Aged; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Blo | 1992 |
[Comment on the contribution by C. Hief, K. Frohner, A. Podczeck, W. Kaltenbrunner, M. Nürnberg and K. Steinbach: Value of a provocation test with diprafenone in patients with bifascicular block].
Topics: Ajmaline; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Heart Block; Humans; Propafenone | 1992 |
[Value of a provocation test with diprafenone in patients with bifascicular block].
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; | 1992 |
[Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle-Branch Block; Cardiac Complexes, Prematur | 1986 |
[Self-poisoning with propafenone. Apropos of a case].
Topics: Adult; Blood Pressure; Heart Block; Humans; Male; Propafenone; Seizures; Suicide, Attempted | 1988 |
Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.
Topics: Angina Pectoris; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Block | 1987 |
Effects of propafenone on sinus nodal and ventricular automaticity: in vitro and in vivo correlation.
Topics: Animals; Dogs; Female; Heart Block; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Membran | 1987 |
[Intense symptomatic bradycardia caused by sinoauricular block: severe adverse reaction caused by propafenone].
Topics: Aged; Bradycardia; Heart Block; Humans; Male; Propafenone | 1987 |
Propafenone ingestion.
Topics: Bundle-Branch Block; Child, Preschool; Electrocardiography; Emergencies; Heart Arrest; Heart Block; | 1987 |
A method for evaluating different modes of action of an antiarrhythmic drug in man. The effects of propafenone on sinus nodal functions.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Autonomic Nervous S | 1985 |